Table 3.
Summary of statistic results in our meta-analysis and subgroup analysis.
| Subgroup | SMD | 95% CI | P-value | Heterogeneity | |
|---|---|---|---|---|---|
| Hcy | AD | 0.689 | [0.569, 0.809] | 0.000 | 85.2% |
| VAD | 1.228 | [0.818, 1.639] | 0.000 | 90.9% | |
| Caucasian | 0.872 | [0.727, 1.016] | 0.000 | 89% | |
| Asian | 0.546 | [0.368, 0.723] | 0.000 | 69.1% | |
| Age 60–70 | 0.519 | [0.288, 0.75] | 0.000 | 50.4% | |
| Age 70–80 | 0.826 | [0.695, 0.959] | 0.000 | 86.7% | |
| Age 80–90 | 0.961 | [0.438, 1.485] | 0.000 | 94.2% | |
| AD vs. VAD Male Female |
−0.278 1.24 0.71 |
[−0.466, −0.09] [0.91–1.58] [0.53–0.88] |
0.004 0.000 0.000 |
65.7% 90.7% 87.9% |
|
| Folate | AD | −0.503 | [−0.644, −0.362] | 0.000 | 85.5% |
| VAD | −0.796 | [−1.2, −0.393] | 0.000 | 82.6% | |
| Caucasian | −0.676 | [−0.856, −0.497] | 0.000 | 87.8% | |
| Asian | −0.256 | [−0.377, −0.314] | 0.000 | 46.2% | |
| Age 60–70 | −0.262 | [−0.486, −0.037] | 0.022 | 85.8% | |
| Age 70–80 | −0.574 | [−0.731, −0.418] | 0.000 | 85.4% | |
| Age 80–90 | −0.69 | [−1.190, −0.193] | 0.000 | 90.5% | |
| AD vs. VAD Male Female |
0.032 −0.64 −0.57 |
[−0.132, 0.196] [−0.97, −0.3] [−0.74, −0.39] |
0.703 0.000 0.000 |
20.2% 84.1% 85.4% |
SMD, standard mean differences; 95 %CI, confidence interval.